Nagpur
+919405117673
+919405117673

Decitabine 50mg Injection Manufacturer & Global Exporter in India | Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical exporter from India, specializing in high-quality oncology formulations including Decitabine 50mg Injection, widely used in the treatment of blood-related cancers. We ensure premium-grade manufacturing standards, strict quality control, and fast international shipping to major global markets including: United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. 💉 About Decitabine 50mg Injection Decitabine is a chemotherapy medication belonging to the class of hypomethylating agents. It is primarily used in oncology treatments under strict medical supervision. 🏥 Usage / Indications Decitabine 50mg Injection is used for: Treatment of myelodysplastic syndromes (MDS) Certain types of acute myeloid leukemia (AML) Blood and bone marrow related cancers Management of abnormal blood cell production 💊 Dosage Information Administered intravenously only under medical supervision Dosage depends on patient condition, body surface area, and clinical response Typically given in cycles as prescribed by an oncologist Self-administration is strictly not recommended ⚠️ Side Effects Possible side effects may include: Low white blood cell count (increased infection risk) Anemia and fatigue Nausea and vomiting Fever or chills Injection site reactions Liver function changes (in some cases) ⚠️ Patients must be monitored regularly during therapy. 🌐 Global Export & Supply by Cordium Pharmaceuticals Pvt Ltd We are committed to providing reliable and timely pharmaceutical exports with: GMP-certified manufacturing standards Secure packaging and documentation Fast global logistics support Export compliance for regulated markets 📦 Fast Delivery Available To: USA | Germany | UK | Netherlands | South Africa | UAE | Brazil 📞 Contact Us for Bulk Orders & Export Inquiry 📱 WhatsApp: +91-9405117673 📧 Email: info@cordiumpharma.com
 2026-04-18T05:22:29

Keywords